Analgesics
Antiandrogens
Antihistamines
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
 
next
study
previous
study
c19early.org COVID-19 treatment researchSelect treatment..Select..
Melatonin Meta
Metformin Meta
Antihistamines Meta
Azvudine Meta Molnupiravir Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

 

Neurological Complications and Outcomes in Critically Ill Patients With COVID-19: Results From International Neurological Study Group From the COVID-19 Critical Care Consortium

Ahmad et al., The Neurohospitalist, doi:10.1177/19418744241292487, ACTRN12620000421932
Oct 2024  
  Post
  Facebook
Share
  Source   PDF  
Prospective observational study of 713 critically ill COVID-19 patients in 11 countries showing 13% incidence of neurological complications. Patients with neurological complications had higher mortality and worse functional outcomes at discharge.
Ahmad et al., 15 Oct 2024, prospective, multiple countries, peer-reviewed, median age 56.0, 17 authors, study period 7 January, 2020 - 23 June, 2022, trial ACTRN12620000421932. Contact: sahmad37@jhmi.edu.
This PaperMiscellaneousAll
Neurological Complications and Outcomes in Critically Ill Patients with COVID-19: Results from International Neurological Study Group from the COVID-19 Critical Care Consortium
Syed Ameen Ahmad, Yunis Mayasi, Lan Kelly, Jacky Suen, Denise Battaglini, Gianluigi Li Bassi, John F Fraser, Lavien Premraj, Rakesh C Arora, Diego Bastos, Glenn Whitman, Matthew Griffee, Jonathon P Fanning, Chiara Robba, Sung-Min Cho
doi:10.21203/rs.3.rs-3210705/v1
Background: In this COVID-19 Critical Care Consortium (CCCC) sub-study, we quali ed neurological complications associated with COVID-19 infection, including incidence and outcomes across many countries. Methods: The CCCC is an international, multicenter study. Eligible patients were COVID-19 patients admitted to intensive care units (ICU) in hospitals across 23 centers between January 7th, 2020, to June 23rd, 2022. Incidence of neurological complications was estimated as the number of events per hospital days and per admission using Poisson regression. Associations between neurological complications and clinical risk factors were assessed using multivariable Poisson regression. Results: 713 patients were included, with a median age of 56 years (interquartile range (IQR)=45-65), of which 272 (38.1%) were female. Median ICU days was 14 (IQR=7-25). Neurological complications were reported in 61/480 patients (12.7%) with the most common being ischemic stroke (2.9%), intracranial hemorrhage (ICH) (2.8%), and seizures (2.6%). After adjusting for sex, age, pandemic era, country income status, comorbid neurological conditions, and mechanical ventilation or extracorporeal membrane oxygenation (ECMO), multivariable analysis for neurological complications per admitted days showed comorbid neurological conditions (incidence rate ratio (IRR)=6.35, 2.57-15.7) were an independent risk factor for ischemic stroke. ECMO (IRR=5.32, 1.52-18.6), low-middle income countries (LMIC) vs high income countries (HIC) (IRR=4.70, 1.62-13.7), and age >55 (IRR=3.66, 1.23-10.9) were independent risk factors for ICH. Co-morbid neurological conditions (IRR=3.43, 1.11-10.6), LMIC vs HIC (IRR=8.69, 2.15-35.2), July-December 2020 vs January-June 2020 (IRR=0.17, 0.04-0.69) and age >55 (IRR=4.05, 1.15-14.3) were independent risk factors for seizure. 6.8% of patients with neurological complications had favorable outcomes (modi ed Rankin Score (mRS) < 3) at discharge compared to 13.2% of patients without complications. Conclusions: Neurological complications were not uncommon in patients with COVID-19 infection. Being from an LMIC was an independent risk factor for neurological complications. Decisionmaking should incorporate salient risk factors to inform the management of severe COVID-19 infection.
1. This manuscript complies with all instructions to authors. 2. The authorship requirements have been met and the nal manuscript was approved by all authors. 3. The manuscript has not been published elsewhere and is not under consideration by another journal. The Covid-19 Critical Care Consortium main study and its amendments have been approved by the Regional Ethics Committee of participating sites. Trial registration number: ACTRN12620000421932. Supplementary Files This is a of supplementary les associated with this preprint. Click to download. Neurosubstudytables gures.docx
References
Abbas, Chaudhary, COVID-19 Associated Coagulopathy Resulting in Cerebral Venous Thrombosis and Pulmonary Embolism, Cureus
Aghagoli, Neurological Involvement in COVID-19 and Potential Mechanisms: A Review, Neurocrit Care
Bassi, Design and rationale of the COVID-19 Critical Care Consortium international, multicentre, observational study, BMJ Open
Battaglini, Neurological Manifestations of Severe SARS-CoV-2 Infection: Potential Mechanisms and Implications of Individualized Mechanical Ventilation Settings, Front Neurol
Battaglini, Neurological manifestations of SARS-CoV-2 infection: protocol for a sub-analysis of the COVID-19 Critical Care Consortium Observational Study, Front Neurol online ahead, doi:2022.10.3389/fmed.2022.930217
Bellani, Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries, JAMA
Chen, Tan, Mo, Zhang, The blood-brain barrier in health, neurological diseases, and COVID-19, Fundamental Res
Chiarini, Cho, Whitman, Rasulo, Lorusso, Brain Injury in Extracorporeal Membrane Oxygenation: A Multidisciplinary Approach, Semin Neurol
Cho, Ischemic and Hemorrhagic Stroke Among Critically Ill Patients With Coronavirus Disease
Chou, Global Incidence of Neurological Manifestations Among Patients Hospitalized With COVID-19-A Report for the GCS-NeuroCOVID Consortium and the ENERGY Consortium, JAMA Netw Open
Drake, Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study, The Lancet
Feigin, The global burden of neurological disorders: translating evidence into policy, Lancet Neurol
Glaser, A Population-Based Study of Neurologic Manifestations of Severe In uenza A(H1N1)pdm09 in California, Clin Infect Dis
Gorman, Kane, Mcauley, Acute respiratory distress syndrome in adults: diagnosis, outcomes, long-term sequelae, and management, The Lancet
He, Bai, Zhu, Huang, Zhang, What can the neurological manifestations of COVID-19 tell us: a meta-analysis, J Translational Med
Huth, Neurological Manifestations of Coronavirus Disease 2019: A Comprehensive Review and Meta-Analysis of the First 6 Months of Pandemic Reporting, Front Neurol
Josephson, Kilic, Michler, Socioeconomic impacts of COVID-19 in low-income countries, Nat Hum Behav
Kannapadi, Neurological Complications in COVID-19 Patients With ECMO Support: A Systematic Review and Meta-Analysis, Heart Lung Circ
Kannapadi, Neurological Complications in COVID-19 Patients With ECMO Support: A Systematic Review and Meta-Analysis, Heart Lung and Circulation
Krasemann, The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2, Stem Cell Reports
Libbey, Fujinami, Neurotropic viral infections leading to epilepsy: focus on Theiler's murine encephalomyelitis virus, Future Virol
Machhi, The Natural History, Pathobiology, and Clinical Manifestations of SARS-CoV-2 Infections, J Neuroimmune Pharmacol
Manolis, Manolis, Manolis, Papatheou, Melita, COVID-19 Infection: Viral Macro-and Micro-Vascular Coagulopathy and Thromboembolism/Prophylactic and Therapeutic Management, J Cardiovasc Pharmacol Therap
Merkler, Risk of Ischemic Stroke in Patients With Coronavirus Disease 2019 (COVID-19) vs Patients With In uenza, JAMA Neurol
Perico, Immunity, endothelial injury and complement-induced coagulopathy in COVID-19, Nat Rev Nephrol
Rass, Neurological outcomes 1 year after COVID-19 diagnosis: A prospective longitudinal cohort study, Eur J Neurol
Robba, Battaglini, Pelosi, Rocco, Multiple organ dysfunction in SARS-CoV-2: MODS-CoV-2, Expert Rev Respir Med
Robba, Coagulative Disorders in Critically Ill COVID-19 Patients with Acute Distress Respiratory Syndrome: A Critical Review, J Clin Med
Romagnolo, Neurological comorbidity and severity of COVID-19, J Neurol
Sagris, COVID-19 and ischemic stroke, Eur J Neurol
Sashindranath, Nandurkar, Endothelial Dysfunction in the Brain, Stroke
Savarraj, Brain injury, endothelial injury and in ammatory markers are elevated and express sex-speci c alterations after COVID-19, J Neuroin amm
Thakur, Risk Factors for New Neurologic Diagnoses in Hospitalized Patients With COVID-19: A Case-Control Study in New York City, Neurology: Clin Pract
Von Elm, The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies, The Lancet
Yassin, Neurological manifestations and complications of coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis, BMC Neurol
Yu, Lessons from the contrast dye shortage during COVID-19: A narrative review, Med (Baltim)
Zou, Donner, Extension of the modi ed Poisson regression model to prospective studies with correlated binary data, Stat Methods Med Res
{ 'indexed': { 'date-parts': [[2024, 10, 16]], 'date-time': '2024-10-16T04:13:03Z', 'timestamp': 1729051983909}, 'reference-count': 40, 'publisher': 'SAGE Publications', 'license': [ { 'start': { 'date-parts': [[2024, 10, 15]], 'date-time': '2024-10-15T00:00:00Z', 'timestamp': 1728950400000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://journals.sagepub.com/page/policies/text-and-data-mining-license'}], 'funder': [ { 'DOI': '10.13039/501100001794', 'name': 'University of Queensland', 'doi-asserted-by': 'publisher', 'id': [{'id': '10.13039/501100001794', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}, {'name': 'The Health Research Board of Ireland'}, { 'DOI': '10.13039/100000865', 'name': 'The Bill & Melinda Gates Foundation', 'doi-asserted-by': 'publisher', 'award': ['INV-034765'], 'id': [{'id': '10.13039/100000865', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}, { 'DOI': '10.13039/100010230', 'name': 'Queensland Health', 'doi-asserted-by': 'publisher', 'id': [{'id': '10.13039/100010230', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}, {'name': 'Advance Queensland Fellowship Program'}, {'name': 'The BITRECS Fellowship'}, { 'DOI': '10.13039/501100018853', 'name': 'Common Good', 'doi-asserted-by': 'publisher', 'id': [{'id': '10.13039/501100018853', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}, {'name': 'The Wesley Medical Research'}, { 'DOI': '10.13039/501100022617', 'name': 'Fisher and Paykel Healthcare', 'doi-asserted-by': 'publisher', 'id': [{'id': '10.13039/501100022617', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}], 'content-domain': {'domain': ['journals.sagepub.com'], 'crossmark-restriction': True}, 'abstract': '<jats:sec><jats:title>Background</jats:title><jats:p> In this COVID-19 Critical Care ' 'Consortium (CCCC) sub-study, we qualified neurological complications associated with ' 'SARS-CoV2 infection. </jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p> ' 'The CCCC is an international, multicenter study. Eligible patients were COVID-19 patients ' 'admitted to intensive care units (ICU) across 23 centers between 1/7/2020 to 6/23/2022. ' 'Incidence of neurological complications was estimated as number of events per hospital days ' 'and per admission using Poisson regression. Associations between neurological complications ' 'and risk factors were assessed using multivariable Poisson regression. ' '</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p> 713 patients were ' 'included. Median age = 56\xa0years (interquartile range (IQR) = 45-65). Neurological ' 'complications reported in 61/480 patients (12.7%) with the majority being ischemic stroke ' '(2.9%), intracranial hemorrhage (ICH) (2.8%), and seizures (2.6%). Multivariable analysis for ' 'neurological complications per admitted days showed comorbid neurological conditions ' '(incidence rate ratio (IRR) = 6.35, 2.57-15.7) were an independent risk factor for ischemic ' 'stroke. Extracorporeal membrane oxygenation (IRR = 5.32, 1.52-18.6), low-middle income ' 'countries (LMIC) vs high income countries (HIC) (IRR = 4.70, 1.62-13.7), and age &gt;55 (IRR ' '= 3.66, 1.23-10.9) were independent risk factors for ICH. Co-morbid neurological conditions ' '(IRR = 3.43, 1.11-10.6), LMIC vs HIC (IRR = 8.69, 2.15-35.2), July-December 2020 vs ' 'January-June 2020 (IRR = 0.17, 0.04-0.69) and age &gt;55 (IRR = 4.05, 1.15-14.3) were ' 'independent risk factors for seizure. ' '</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p> Decision-making ' 'should incorporate salient risk factors to inform management of SARS-CoV2 infection and avoid ' 'neurological complications. </jats:p></jats:sec>', 'DOI': '10.1177/19418744241292487', 'type': 'journal-article', 'created': { 'date-parts': [[2024, 10, 15]], 'date-time': '2024-10-15T07:22:36Z', 'timestamp': 1728976956000}, 'update-policy': 'http://dx.doi.org/10.1177/sage-journals-update-policy', 'source': 'Crossref', 'is-referenced-by-count': 0, 'title': 'Neurological Complications and Outcomes in Critically Ill Patients With COVID-19: Results From ' 'International Neurological Study Group From the COVID-19 Critical Care Consortium', 'prefix': '10.1177', 'author': [ { 'ORCID': 'http://orcid.org/0000-0002-6179-5252', 'authenticated-orcid': False, 'given': 'Syed Ameen', 'family': 'Ahmad', 'sequence': 'first', 'affiliation': [ { 'name': 'Department of Neurosciences Critical Care, Departments of ' 'Neurology, Neurosurgery, Anesthesiology and Critical Care ' 'Medicine, Johns Hopkins University School of Medicine, ' 'Baltimore, MD, USA'}]}, { 'given': 'Yunis', 'family': 'Mayasi', 'sequence': 'additional', 'affiliation': [ { 'name': 'Department of Neurosciences Critical Care, Departments of ' 'Neurology, Neurosurgery, Anesthesiology and Critical Care ' 'Medicine, Johns Hopkins University School of Medicine, ' 'Baltimore, MD, USA'}]}, { 'given': 'Thu-Lan', 'family': 'Kelly', 'sequence': 'additional', 'affiliation': [ { 'name': 'School of Public Health & Social Work, Queensland University of ' 'Technology, Brisbane, QLD, Australia'}]}, { 'given': 'Nicole', 'family': 'White', 'sequence': 'additional', 'affiliation': [ { 'name': 'School of Public Health & Social Work, Queensland University of ' 'Technology, Brisbane, QLD, Australia'}]}, { 'given': 'Jacky', 'family': 'Suen', 'sequence': 'additional', 'affiliation': [ { 'name': 'Critical Care Research Group, The Prince Charles Hospital, ' 'Brisbane, QLD, Australia'}, { 'name': 'Faculty of Medicine University of Queensland, Brisbane, QLD, ' 'Australia'}]}, { 'given': 'Denise', 'family': 'Battaglini', 'sequence': 'additional', 'affiliation': [ { 'name': 'Anesthesia and Intensive Care, IRCCS Policlinico San Martino, ' 'Genoa, Italy'}, { 'name': 'Department of Medicine, University of Barcelona, Barcelona, ' 'Spain'}]}, { 'given': 'Gianluigi Li', 'family': 'Bassi', 'sequence': 'additional', 'affiliation': [ { 'name': 'Critical Care Research Group, The Prince Charles Hospital, ' 'Brisbane, QLD, Australia'}, { 'name': 'Faculty of Medicine University of Queensland, Brisbane, QLD, ' 'Australia'}, {'name': 'Queensland University of Technology, Brisbane, QLD, Australia'}, { 'name': 'Institut d’Investigacions Biomèdiques August Pi i Sunyer, ' 'Barcelona, Spain'}]}, { 'given': 'John F.', 'family': 'Fraser', 'sequence': 'additional', 'affiliation': [ { 'name': 'Critical Care Research Group, The Prince Charles Hospital, ' 'Brisbane, QLD, Australia'}, { 'name': 'Faculty of Medicine University of Queensland, Brisbane, QLD, ' 'Australia'}, {'name': 'Queensland University of Technology, Brisbane, QLD, Australia'}, { 'name': 'Critical Care Medicine, UnitingCare Health, Brisbane, QLD, ' 'Australia'}]}, { 'given': 'Lavien', 'family': 'Premraj', 'sequence': 'additional', 'affiliation': [ { 'name': 'Critical Care Research Group, The Prince Charles Hospital, ' 'Brisbane, QLD, Australia'}, { 'name': 'Griffith University School of Medicine, Gold Coast, QLD, ' 'Australia'}]}, { 'given': 'Rakesh C.', 'family': 'Arora', 'sequence': 'additional', 'affiliation': [ { 'name': 'Harrington Heart and Vascular Institute, University Hospitals, ' 'Cleveland, OH, USA'}, { 'name': 'Division of Cardiac Surgery, Department of Surgery, Case Western ' 'Reserve University, Cleveland, OH, USA'}]}, { 'given': 'Diego', 'family': 'Bastos', 'sequence': 'additional', 'affiliation': [{'name': 'Hospital Sao Camilo de Esteio, Esteio, Brazil'}]}, { 'given': 'Glenn', 'family': 'Whitman', 'sequence': 'additional', 'affiliation': [ { 'name': 'Department of Neurosciences Critical Care, Departments of ' 'Neurology, Neurosurgery, Anesthesiology and Critical Care ' 'Medicine, Johns Hopkins University School of Medicine, ' 'Baltimore, MD, USA'}]}, { 'given': 'Matthew', 'family': 'Griffee', 'sequence': 'additional', 'affiliation': [ { 'name': 'Department of Anesthesiology and Perioperative Medicine, ' 'University of Utah, Salt Lake City, UT, USA'}]}, { 'given': 'Jonathon P.', 'family': 'Fanning', 'sequence': 'additional', 'affiliation': [ { 'name': 'Critical Care Research Group, The Prince Charles Hospital, ' 'Brisbane, QLD, Australia'}, { 'name': 'Faculty of Medicine University of Queensland, Brisbane, QLD, ' 'Australia'}, { 'name': 'Critical Care Medicine, UnitingCare Health, Brisbane, QLD, ' 'Australia'}]}, { 'given': 'Chiara', 'family': 'Robba', 'sequence': 'additional', 'affiliation': [ { 'name': 'Anesthesia and Intensive Care, IRCCS Policlinico San Martino, ' 'Genoa, Italy'}, { 'name': 'Department of Surgical Sciences and Integrated Diagnostics, ' 'University of Genoa, Genoa, Italy'}]}, { 'given': 'Sung-Min', 'family': 'Cho', 'sequence': 'additional', 'affiliation': [ { 'name': 'Department of Neurosciences Critical Care, Departments of ' 'Neurology, Neurosurgery, Anesthesiology and Critical Care ' 'Medicine, Johns Hopkins University School of Medicine, ' 'Baltimore, MD, USA'}]}, {'name': 'the COVID-19 Critical Care Consortium', 'sequence': 'additional', 'affiliation': []}], 'member': '179', 'published-online': {'date-parts': [[2024, 10, 15]]}, 'reference': [ { 'key': 'bibr1-19418744241292487', 'doi-asserted-by': 'publisher', 'DOI': '10.1080/17476348.2020.1778470'}, { 'key': 'bibr2-19418744241292487', 'doi-asserted-by': 'publisher', 'DOI': '10.1001/jamanetworkopen.2021.12131'}, { 'key': 'bibr3-19418744241292487', 'doi-asserted-by': 'publisher', 'DOI': '10.1186/s12883-021-02161-4'}, { 'key': 'bibr4-19418744241292487', 'doi-asserted-by': 'publisher', 'DOI': '10.1186/s12967-021-03039-2'}, { 'key': 'bibr5-19418744241292487', 'doi-asserted-by': 'publisher', 'DOI': '10.3389/fneur.2020.00845'}, { 'key': 'bibr6-19418744241292487', 'doi-asserted-by': 'publisher', 'DOI': '10.1161/STROKEAHA.120.032711'}, { 'key': 'bibr7-19418744241292487', 'doi-asserted-by': 'publisher', 'DOI': '10.1186/s12974-021-02323-8'}, { 'key': 'bibr8-19418744241292487', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.stemcr.2021.12.011'}, { 'key': 'bibr9-19418744241292487', 'first-page': 'e19602', 'volume': '13', 'author': 'Abbas Z', 'year': '2021', 'journal-title': 'Cureus'}, { 'key': 'bibr10-19418744241292487', 'doi-asserted-by': 'publisher', 'DOI': '10.1177/1074248420958973'}, { 'key': 'bibr11-19418744241292487', 'doi-asserted-by': 'publisher', 'DOI': '10.3390/jcm10010140'}, { 'key': 'bibr12-19418744241292487', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.fmre.2022.03.003'}, { 'key': 'bibr13-19418744241292487', 'doi-asserted-by': 'publisher', 'DOI': '10.1055/s-0041-1726284'}, { 'key': 'bibr14-19418744241292487', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.hlc.2021.10.007'}, { 'key': 'bibr15-19418744241292487', 'doi-asserted-by': 'publisher', 'DOI': '10.1097/CCM.0000000000005209'}, { 'key': 'bibr16-19418744241292487', 'doi-asserted-by': 'publisher', 'DOI': '10.3389/fneur.2021.664599'}, { 'key': 'bibr17-19418744241292487', 'doi-asserted-by': 'publisher', 'DOI': '10.1111/ene.15307'}, { 'key': 'bibr18-19418744241292487', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/S0140-6736(21)00799-6'}, { 'key': 'bibr19-19418744241292487', 'doi-asserted-by': 'publisher', 'DOI': '10.1136/bmjopen-2020-041417'}, { 'key': 'bibr20-19418744241292487', 'doi-asserted-by': 'publisher', 'DOI': '10.3389/fmed.2022.930217'}, { 'key': 'bibr21-19418744241292487', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/S0140-6736(07)61602-X'}, { 'key': 'bibr22-19418744241292487', 'unstructured': 'World Bank. New World Bank country classifications by income level: ' '2021-2022 [Internet]. The World Bank; 2021 [cited 2023 May 3]. Available ' 'from: ' 'https://blogs.worldbank.org/en/opendata/new-world-bank-country-classifications-income-level-2021-2022'}, { 'key': 'bibr23-19418744241292487', 'doi-asserted-by': 'publisher', 'DOI': '10.1177/0962280211427759'}, { 'key': 'bibr24-19418744241292487', 'doi-asserted-by': 'publisher', 'DOI': '10.1001/jamaneurol.2020.2730'}, { 'key': 'bibr25-19418744241292487', 'doi-asserted-by': 'publisher', 'DOI': '10.1038/s41581-020-00357-4'}, { 'key': 'bibr26-19418744241292487', 'doi-asserted-by': 'publisher', 'DOI': '10.1007/s11481-020-09944-5'}, { 'key': 'bibr27-19418744241292487', 'doi-asserted-by': 'publisher', 'DOI': '10.1111/ene.15008'}, { 'key': 'bibr28-19418744241292487', 'doi-asserted-by': 'publisher', 'DOI': '10.1007/s12028-020-01049-4'}, { 'key': 'bibr29-19418744241292487', 'doi-asserted-by': 'publisher', 'DOI': '10.2217/fvl.11.107'}, { 'key': 'bibr30-19418744241292487', 'doi-asserted-by': 'publisher', 'DOI': '10.1093/cid/cis454'}, { 'key': 'bibr31-19418744241292487', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/S0140-6736(22)01439-8'}, { 'key': 'bibr32-19418744241292487', 'doi-asserted-by': 'publisher', 'DOI': '10.1001/jama.2016.0291'}, { 'key': 'bibr33-19418744241292487', 'doi-asserted-by': 'publisher', 'DOI': '10.1212/WNL.0000000000208081'}, { 'key': 'bibr34-19418744241292487', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/S1474-4422(19)30411-9'}, { 'key': 'bibr35-19418744241292487', 'doi-asserted-by': 'publisher', 'DOI': '10.1038/s41562-021-01096-7'}, { 'key': 'bibr36-19418744241292487', 'unstructured': 'LSHTM. COVID-19 control in low-income settings and displaced ' 'populations: what can realistically be done?|LSHTM. ' 'https://www.lshtm.ac.uk/newsevents/news/2021/covid-19-control-low-income-settings-and-displaced-populations-what-can ' '(2021).'}, { 'key': 'bibr37-19418744241292487', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.hrtlng.2024.06.015'}, { 'key': 'bibr38-19418744241292487', 'doi-asserted-by': 'publisher', 'DOI': '10.1007/s00415-020-10123-y'}, { 'key': 'bibr39-19418744241292487', 'doi-asserted-by': 'publisher', 'DOI': '10.1212/CPJ.0000000000200006'}, { 'key': 'bibr40-19418744241292487', 'doi-asserted-by': 'publisher', 'DOI': '10.1097/MD.0000000000032286'}], 'container-title': 'The Neurohospitalist', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://journals.sagepub.com/doi/pdf/10.1177/19418744241292487', 'content-type': 'application/pdf', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://journals.sagepub.com/doi/full-xml/10.1177/19418744241292487', 'content-type': 'application/xml', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://journals.sagepub.com/doi/pdf/10.1177/19418744241292487', 'content-type': 'unspecified', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'deposited': { 'date-parts': [[2024, 10, 15]], 'date-time': '2024-10-15T07:22:53Z', 'timestamp': 1728976973000}, 'score': 1, 'resource': {'primary': {'URL': 'https://journals.sagepub.com/doi/10.1177/19418744241292487'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2024, 10, 15]]}, 'references-count': 40, 'alternative-id': ['10.1177/19418744241292487'], 'URL': 'http://dx.doi.org/10.1177/19418744241292487', 'relation': {}, 'ISSN': ['1941-8744', '1941-8752'], 'subject': [], 'container-title-short': 'The Neurohospitalist', 'published': {'date-parts': [[2024, 10, 15]]}}
Late treatment
is less effective
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit